Despite Medicare Sanction Risks, Elevance Health Sees 7 Trillion Won Market Cap Surge in One Day

Elevance Health Inc. (ELV), a U.S. health insurer, closed on the New York Stock Exchange at $322.20, up 7.14% from the previous session. This gain added roughly $5.4 billion to its market capitalization, bringing it to about $71.1 billion. Trading volume reached 1.08 million shares, reflecting a partial rebound from recent losses tied to Medicare sanction concerns.

Earlier this year, the U.S. Centers for Medicare & Medicaid Services threatened to bar new enrollments and curb certain marketing activities for Medicare Advantage and prescription drug plans, citing violations in risk-adjusted data submissions. That announcement drove Elevance Health’s shares down by as much as 11% in early March amid heightened regulatory risk. Despite this, strong first-quarter earnings, a dividend increase, and institutional ownership in the high-80% range fueled $300 million to $500 million in daily trading volumes at the end of March and start of April, amplifying share-price volatility.

Elevance Health is one of the largest private health insurers in the United States, providing health insurance and care-management services to commercial, Medicare, and Medicaid members under the Blue Cross Blue Shield brands. Formerly known as Anthem until its 2022 rebranding, the company is now expanding its healthcare services and digital-health capabilities through brands such as Carelon.